Clinical Trials Management, LLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Hidradenitis suppurativa2 trials
• Ulcerative colitis1 trial

Phase

• Phase 23 trials
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting4 trials
• Completed1 trial

Lead sponsor

• Bluefin Biomedicine, Inc.2 trials
• Acrotech Biopharma Inc.1 trial
• Eli Lilly and Company1 trial
• Zura Bio Inc1 trial

Running trials

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  NCT07287644· Phase 2/3· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

  NCT06993610· Phase 2· Zura Bio Inc· Source

• Active, not recruiting

  A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  NCT06598943· Phase 2· Eli Lilly and Company· Source

Closed trials

• Completed

  A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

  NCT05571943· Phase 3· Acrotech Biopharma Inc.· Source